TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04288492

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Respiratory biofeedback
Description: Repeat the inspiration and exhalation breaths for a fixed period of time using a biofeedback device (ResCalm)
Study: NCT05580796

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KSH01 injection
Description: TCR-T cell injection
Study: NCT04993391

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JS111(AP-L1898 Capsules)
Description: 40 mg, QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JS111(AP-L1898 Capsules)
Description: 80 mg, QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JS111(AP-L1898 Capsules)
Description: 160 mg, QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JS111(AP-L1898 Capsules)
Description: 240 mg, QD

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JS111(AP-L1898 Capsules)
Description: 320 mg, QD
Study: NCT06750991

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CDR-CHOP
Description: Rituximab 375 mg/m2 D1 Cyclophosphamide 750 mg/m2 D2 Doxorubicin 50 mg/m2 D2 Vincristine 1.4 mg/m2 D2 Prednisone 69 mg.m2 D2-6 Chidamide 20 mg/d D1,4,8,11 Decitabine 10 mg/m2 D-5 - -1
Study: NCT06751316

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional Pulpectomy
Description: Removal of radicular pulp tissue, placing Zinc Oxide/Eugenol and covered by stainless steel crown

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MTA Pulpotomy
Description: Removal of coronal pulp tissue, placing MTA and covered by stainless steel crown
Study: NCT06748807

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: APRVplus
Description: Early Pathophysiology-driven Airway Pressure Release Ventilation (APRVplus)

Intervention type: PROCEDURE
Group type: OTHER
Intervention: TCAV
Description: Time-Controlled Adaptive Ventilation (TCAV)
Study: NCT06748222

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness (MAPs) Live Online
Description: Exercises include breath, body, and sound meditations; eating and walking meditations; managing pain; working with difficult thoughts and emotions; and cultivating loving kindness. Home practice is a key component of MAPs, and participants will be instructed to practice mindfulness techniques daily, beginning with 5 minutes daily and increasing to 20 minutes daily using guided meditations. Attendance in the group sessions and home practice will be tracked to determine dose of the intervention received.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness (MAPs) Digital App
Description: The digital program is sequential with new content and exercises building on previous sessions. Lessons and other materials are gradually unlocked as participants progress through the program. Engagement with the MAPs App will be tracked to determine dose of the intervention received.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Meditation Only Control Group
Description: Use of the meditations will be tracked to determine dose of the intervention received.
Study: NCT06749626

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: progressive relaxation exercise
Description: Relaxation exercises CD developed by the Turkish Psychologists Association; It consists of muscle exercises, rhythmic breathing and music recital. The CD content, which includes relaxation exercises accompanied by music, was prepared by Psychologist Elif Kabak and voiced by Tülay Bursa. The CD, which includes deep breathing and muscle relaxation exercises, consists of three parts. The first section includes the definition of deep relaxation, the purpose of relaxation exercises and the rules to be considered in exercise practice. In the second part; There are relaxation exercises with audio instructions accompanied by streaming sounds. The third part contains relaxation music without instructions. After the information in the first part of the CD is explained to the patients in the experimental group, the second part, which lasts only approximately 30 minutes, will be administered under the supervision of the researcher. However, since the patients have undergone abdominal surgery, the
Study: NCT06748235

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intensive Strength Training
Description: Comprehensive Hand Repetitive Intensive Strength Training and Routine Physical Therapy 60 minutes per session, three sessions a week, at a total of 30 sessions per ten weeks. Comprehensive hand repetitive intensive strength training included treadmill training for the upper limb with body weight supporting the using upper limb. The posture of an arm swing was to maintain the joints of the elbows and wrist as much as possible, and the shoulder joint was allowed to be flexed by 160 degrees .The posture of the arm stance supported the weight using metacarpal heads, hands, and elbows, and the shoulder joints were allowed to be flexed by 90 degrees.

Intervention type: OTHER
Group type: OTHER
Intervention: Routine Physical Therapy
Description: Received 60 minutes per a session, three sessions a week, at a total of 30 sessions per 10 weeks by creating a home program, which consisted of a total of 8 exercises that enhanced the muscular strength of the upper limb including the triceps brachii and extensor carpi radialis, and conveyed an effect of reaching the muscles out. flexion and extension muscle strengthening with towel, hand grip and wrist extension muscle strengthening This exercise consisted of shoulder extension muscle, elbow flexion muscle, shoulder abduction muscle, and elbow extension muscle strengthening with a thera band, as well as hand grip, forearm with a velcro board, wrist extension muscle strengthening with sandbag and shoulder abduction-extension muscle strengthening with a thera band.
Study: NCT06750575

Intervention type: DIAGNOSTIC_TEST
Intervention: Invasive measurements
Description: Blood and urine samples will be collected during the study.
Study: NCT06749964

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet-delivered, therapist-assisted, pain-focused CBT based on the psychological flexibility model for chronic pain
Description: 8-session intervention, twice weekly for the first 3 weeks and once weekly for the final 2 weeks (45-60 min each session) aimed at promoting psychological flexibility. Treatment involves a mixture of video and audiotaped presentations and homework activities for the participant.
Study: NCT06750588

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bacteriophage preparation
Description: NTR-101 will be given orally to participants once daily for 7 days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bacteriophage preparation
Description: NTR-101 will be given orally to participants once daily for 7 days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bacteriophage preparation
Description: NTR-101 will be given orally to participants twice daily for 7 days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bacteriophage preparation
Description: NTR-101 will be given orally to participants three times daily for 7 days
Study: NCT06746675

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Healthy Families PrEP Counselling Intervention
Description: Healthy Families-PrEP intervention with HIV-uninfected women with plans for pregnancy in the next year and concerns about or exposure to HIV. Session 1 focuses on providing information about HIV prevention in the context of reproductive goals (using tools with locally developed images), increasing motivation for behavior change, and developing a safer conception plan (e.g., PrEP uptake, PrEP adherence, couples-based counselling and testing, delaying condomless sex until partner serostatus known and, if living with HIV, virally suppressed). Sessions 2 and 3 (conducted at 1 and 3 months) review the safer conception plan and revise as needed (e.g., changes in readiness to initiate PrEP, partner serostatus knowledge) and engaging in problem-solving barriers (including structural) to plan execution, communication skills training, and motivational strategies for successful plan execution. Participants receive quarterly adherence counseling using tools developed by this team.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: No intervention (standard of care)
Description: Uganda Ministry of Health Standard of Care
Study: NCT05190913

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instrumental perineal massage
Description: In the active phase of labor, perineal massage will be performed with an instrument twice with an interval of one hour.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: manual perineal massage
Description: In the active phase of labor, manual perineal massage is performed twice an hour apart.
Study: NCT01004315

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tolterodine
Study: NCT04761471

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TI transcranial electrical stimulation
Description: Participants will undergo transcranial electrical stimulation, which will be delivered with low current amplitudes (\<= 2 mA) established with international safety guidelines for electrical stimulation. Threshold for the current amplitude will be established by participants themselves, such that they cannot distinguish when stimulation is applied and not applied.~Duration of stimulation will not last longer than 30 minutes.
Study: NCT05773534

Intervention type: DIAGNOSTIC_TEST
Intervention: MSOT
Description: Similar as the conventional sonography, the MSOT transducer head is placed on the skin of the examined person above the target organ. But instead of sound waves, energy is applied to the tissue via laser light, leading to constant changes of minimal expansions and contractions (thermoelastic expansion) of different tissue components or molecules. The same transducer head that releases the laser flashes can also detect the emitted ultrasound waves. In the newly configured device (Acuity Echo, iThera Medical GmbH, Munich, CE-certified), an extended spectrum of laser light can be used, enabling among others the derivation of values corresponding to hemoglobin and its oxygenation levels. As hemoglobin concentration and oxygenation status are markers for perfusion, MSOT-based imaging of these parameters could be a highly sensitive and reliable method to analyze muscle perfusion.

Intervention type: DIAGNOSTIC_TEST
Intervention: MSOT
Description: Similar as the conventional sonography, the MSOT transducer head is placed on the skin of the examined person above the target organ. But instead of sound waves, energy is applied to the tissue via laser light, leading to constant changes of minimal expansions and contractions (thermoelastic expansion) of different tissue components or molecules. The same transducer head that releases the laser flashes can also detect the emitted ultrasound waves. In the newly configured device (Acuity Echo, iThera Medical GmbH, Munich, CE-certified), an extended spectrum of laser light can be used, enabling among others the derivation of values corresponding to hemoglobin and its oxygenation levels. As hemoglobin concentration and oxygenation status are markers for perfusion, MSOT-based imaging of these parameters could be a highly sensitive and reliable method to analyze muscle perfusion.
Study: NCT05258851

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ceftazidime-avibactam
Description: Experimental

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colistin
Description: Control
Study: NCT05943041

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GB104(Level 1)
Description: One capsule QD oral administration for 28 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GB104(Level 2)
Description: Three capsules QD oral administration for 28 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GB104(Level 3)
Description: Five capsules QD oral administration for 28 days
Study: NCT06129162

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Star Pen anesthesia device.
Description: Dental local anesthesia injection is given by Star Pen anesthesia device by two injection methods inferior alveolar nerve block and buccal infiltration.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Star Pen anesthesia device.
Description: Dental local anesthesia injection is given by Star Pen anesthesia device by two injection methods inferior alveolar nerve block and buccal infiltration.
Study: NCT05247073

Intervention type: PROCEDURE
Group type: OTHER
Intervention: patients of controlled group with routine closure of episiotomy
Description: Perineal trauma is traditionally repaired in three stages: a continuous locking stitch is inserted to close the vaginal trauma, commencing at the apex of the wound and finishing at the level of the fourchette with a loop knot. The perineal muscles are then re-approximated with three or four interrupted sutures and finally, the perineal skin is closed by inserting continuous subcutaneous or interrupted transcutaneous stitches.~The skin is then closed with inverted interrupted stitches placed in the subcutaneous tissue a few millimeters under the perineal skin edges (not transcutaneously).

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: The Mostafa Maged four-stitch technique fore closure of the episiotomy
Description: Identification of the apex of the episiotomy, then a simple suture is taken (0.5 cm) behind the apex of the episiotomy. First, the needle is inserted at the vaginal mucosa of the right edge of the episiotomy then extract the needle.~The second stitch is inserted on the deep muscle layer of the same side (Right side) of the episiotomy cutting edge then extracting the needle.~Then, insert the needle again on the left side of the episiotomy incision in the deep muscle layer on the left side of the episiotomy incision directing the tip of the needle upwards parallel to the second stitch taken.~The fourth step is inserting the needle in the vaginal mucosa of the left side parallel to the first stitch. Continue suturing the episiotomy incision continuously in the same way till reaching the remnant of the hymen.~Then suture the superficial perineal muscle in a continuous manner and the skin in a subcuticular manner as well.
Study: NCT06467578

Intervention type: DEVICE
Group type: OTHER
Intervention: Breezing Portable Indirect Calorimeter
Description: Indirect calorimeter with face mask and smartphone compatible application
Study: NCT06354062

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Talent management intervention program
Description: Talent management intervention program
Study: NCT06142669

Intervention type: DEVICE
Intervention: EVOLUTION® Revision Tibial System and EVOLUTION® Stemmed CS Femur with the EVOLUTION® MP CS Tibial Insert
Description: Primary knee arthroplasty or a revision knee that requires a revision procedure.
Study: NCT05016687

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CUR-N399
Description: CUR-N399 will be administered as oral capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CUR-N399
Description: CUR-N399 will be administered as oral capsules.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CUR-N399
Description: CUR-N399 will be administered as oral capsules.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules matching CUR-N399 will administered.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules matching CUR-N399 will administered.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules matching CUR-N399 will administered.
Study: NCT06749054

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Lenacapavir
Description: Tablets administered without regard to food

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Subcutaneous Lenacapavir
Description: Administered via subcutaneous injections

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Optimized Background Regimen (OBR)
Description: Optimized background regimen as prescribed by the Investigator
Study: NCT06750848

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chidamide，Fulvestrant，angiogenesis inhibitors
Description: chidamide，30mg，po. biw fulvestrant ，500mg， im., d1(c1d15), q4w angiogenesis inhibitors , according to the doctor's advice
Study: NCT06751303

Intervention type: OTHER
Group type: OTHER
Intervention: Patients that are HRP are given a decision aid for PARPi use
Description: Study created patient decision aid if the first for HRD tested Ovarian Cancer patients
Study: NCT04705805

Intervention type: BEHAVIORAL
Intervention: Self-assessment of olfactory disorders through two questionnaires.
Description: * Assessment of sense of smell or loss of smell using an Analogue Visual Scale~* Carrying out the objective smell test (Sniffin' sticks test) (gold standard)~* Information from two self-questionnaires translated into French: a quality of life questionnaire (The Questionnaire Olfactory Disorders (QOD)) and a self-assessment questionnaire of his olfactory capacities (Self-Mini Olfactory Questionnaire (Self-MOQ))

Intervention type: BEHAVIORAL
Intervention: Self-assessment of olfactory disorders through two questionnaires.
Description: * Assessment of sense of smell or loss of smell using an Analogue Visual Scale~* Carrying out the objective smell test (Sniffin' sticks test) (gold standard)~* Information from two self-questionnaires translated into French: a quality of life questionnaire (The Questionnaire Olfactory Disorders (QOD)) and a self-assessment questionnaire of his olfactory capacities (Self-Mini Olfactory Questionnaire (Self-MOQ))
Study: NCT05287373

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nalu Neurostimulation System for PNS
Description: The Nalu Neurostimulation System for PNS is a peripheral nerve stimulator

Intervention type: OTHER
Group type: OTHER
Intervention: conventional medical management
Description: Conventional medical management

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional medical management
Description: Conventional medical management
Study: NCT04594902

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Infant Behavior Program (IBP)
Description: Infant Behavior Program (IBP) is a home-based adaptation of the Child-Directed Interaction (CDI) phase of Parent-Child Interaction Therapy (PCIT), an evidence-based intervention for early externalizing problems. Consistent with recommendations we maintained core features of CDI and addressed the unique developmental needs of infants. All IBP sessions will completed remotely.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Pediatric Primary Care (EPPC)
Description: Families in EPPC will receive six one-hour home visits where they will receive information about normative developmental and health expectations for their infant. Specifically, therapists will provide education on six topics: (1) cognitive and emotional development; (2) language and social development; (3) safety; (4) feeding and nutrition; (5) sleep; and (6) fitness and activity. All EPPC sessions will completed remotely.
Study: NCT05868265

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enfortumab Vedotin
Description: All patients will receive enfortumab vedotin at 1.25 mg/kg on days 1 and 8 of 21 days cycle, for a total of three cycles.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radical surgery
Description: Radical surgery, such as radical nephroureterectomy, nephrectomy or ureterectomy is to take place within 60 days from the last dose of treatment end of cycle 3 (i.e., cycle 3 day 22).
Study: NCT05584046

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CDAM
Description: Novel drugs such as Traditional Chinese Medicine (TCM) formula that can suppress inflammation may augment tissue healing and reduce activity-related pain in patients suffering from plantar fasciitis. Our team has experiences of using TCM for the treatment of plantar fasciitis. Based on our previous experience, our group has developed a new proprietary topical TCM herbal formula, CDAM, containing Carthami Flos , Dipsaci Radix , Aconiti Lateralis Radix Praeparata and Herba Menthae for the treatment of plantar fasciitis.
Study: NCT04977271

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Description: The Immediate Release generic formulation of this drug will be used due to its ability to be crushed for those patients who rely on parenteral administration of medications.
Study: NCT06450977

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MIND Diet
Description: Daily meals designed to increase adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) dietary pattern.
Study: NCT05176223

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo 68Ga PSMA PET/CT

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gallium Ga 68 Gozetotide
Description: Undergo 68Ga PSMA PET/CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo 68Ga PSMA PET/CT
Study: NCT04120766

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicorandil
Description: 20 mg po qd

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching tablet
Study: NCT05725031

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ephedrine
Description: 70 μg/kg as pretreatment
Study: NCT06450977

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Diet
Description: Daily meals designed to increase fruit, vegetable, and whole grain intake consistent with a healthy American diet.
Study: NCT06097429

Intervention type: DIAGNOSTIC_TEST
Intervention: blood sample for platelet aggregation
Description: evaluate platelet aggregation using light-transmission aggregometry and adenosine diphosphate (ADP)

Intervention type: DIAGNOSTIC_TEST
Intervention: blood sample for platelet aggregation
Description: evaluate platelet aggregation using light-transmission aggregometry and adenosine diphosphate (ADP)
Study: NCT06553222

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Putty bone - Tricalcium phosphate with Collagen gel
Description: Minimally invasive debridement periodontal flap and Bone graft placement to augment the lost alveolar bone
Study: NCT06042699

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral ferrous sulfate
Description: Oral ferrous sulfate 325mg is used as a dietary supplement providing 65mg elemental iron.
Study: NCT06553222

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Putty bone - Tricalcium phosphate with Collagen gel
Description: Minimally invasive debridement periodontal flap and Bone graft placement to augment the lost alveolar bone
Study: NCT05725031

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6
Description: 0.6 mg/kg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.8
Description: 0.8 mg/kg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rocuronium 1.2
Description: 1.2 mg/kg